相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。NitroSynapsin ameliorates hypersynchronous neural network activity in Alzheimer hiPSC models
Swagata Ghatak et al.
MOLECULAR PSYCHIATRY (2021)
α-Synuclein Oligomers Induce Glutamate Release from Astrocytes and Excessive Extrasynaptic NMDAR Activity in Neurons, Thus Contributing to Synapse Loss
Dorit Trudler et al.
JOURNAL OF NEUROSCIENCE (2021)
ApoE4 inhibition of VMAT2 in the locus coeruleus exacerbates Tau pathology in Alzheimer's disease
Seong Su Kang et al.
ACTA NEUROPATHOLOGICA (2021)
Selective removal of astrocytic APOE4 strongly protects against tau-mediated neurodegeneration and decreases synaptic phagocytosis by microglia
Chao Wang et al.
NEURON (2021)
Riluzole, a glutamate modulator, slows cerebral glucose metabolism decline in patients with Alzheimer's disease
Dawn C. Matthews et al.
BRAIN (2021)
Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000-person neuropathological study
Eric M. Reiman et al.
NATURE COMMUNICATIONS (2020)
Effects of Chronic Masitinib Treatment in APPswe/PSEN1dE9 Transgenic Mice Modeling Alzheimer's Disease
Tengfei Li et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
Fyn Tyrosine Kinase Elicits Amyloid Precursor Protein Tyr682 Phosphorylation in Neurons from Alzheimer's Disease Patients
Filomena Iannuzzi et al.
CELLS (2020)
The NLRP3 inflammasome inhibitor OLT1177 rescues cognitive impairment in a mouse model of Alzheimer's disease
Niklas Lonnemann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer's disease patient iPSC-derived cerebral organoids
Jing Zhao et al.
NATURE COMMUNICATIONS (2020)
In Vivo Synaptic Density Imaging with 11C-UCB-J Detects Treatment Effects of Saracatinib in a Mouse Model of Alzheimer Disease
Takuya Toyonaga et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Effect of AZD0530 on Cerebral Metabolic Decline in Alzheimer Disease A Randomized Clinical Trial
Christopher H. van Dyck et al.
JAMA NEUROLOGY (2019)
NLRP3 inflammasome activation drives tau pathology
Christina Ising et al.
NATURE (2019)
Fluoxetine delays the cognitive function decline and synaptic changes in a transgenic mouse model of early Alzheimer's disease
Chun-ni Zhou et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2019)
Comparative profiling of the synaptic proteome from Alzheimer's disease patients with focus on the APOE genotype
Raphael Hesse et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Amyloid beta synaptotoxicity is Wnt-PCP dependent and blocked by fasudil
Katherine J. Sellers et al.
ALZHEIMERS & DEMENTIA (2018)
Impact of SSRI Therapy on Risk of Conversion From Mild Cognitive Impairment to Alzheimer's Dementia in Individuals With Previous Depression
Claudia Bartels et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Fasudil hydrochloride ameliorates memory deficits in rat model of streptozotocin-induced Alzheimer's disease: Involvement of PI3-kinase, eNOS and NF kappa B
Manish Kumar et al.
BEHAVIOURAL BRAIN RESEARCH (2018)
A Systematic Review and Meta-Analysis of the Effectiveness of Acetylcholinesterase Inhibitors and Memantine in Treating the Cognitive Symptoms of Dementia
Ruth Knight et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2018)
Memantine for the Treatment of Dementia: A Review on its Current and Future Applications
Jaume Folch et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Disease-modifying benefit of Fyn blockade persists after washout in mouse Alzheimer's model
Levi M. Smith et al.
NEUROPHARMACOLOGY (2018)
Fasudil in Combination With Bone Marrow Stromal Cells (BMSCs) Attenuates Alzheimer's Disease-Related Changes Through the Regulation of the Peripheral Immune System
Jiezhong Yu et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
Adeno-Associated Viral Vector (Serotype 2)-Nerve Growth Factor for Patients With Alzheimer Disease A Randomized Clinical Trial
Michael S. Rafii et al.
JAMA NEUROLOGY (2018)
Cerebrospinal fluid from Alzheimer patients affects cell-mediated nerve growth factor production and cell survival in vitro
Maria Eriksdotter et al.
EXPERIMENTAL CELL RESEARCH (2018)
Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies
Borislav Dejanovic et al.
NEURON (2018)
Long-term Ameliorative Effects of the Antidepressant Fluoxetine Exposure on Cognitive Deficits in 3 x TgAD Mice
Li Jin et al.
MOLECULAR NEUROBIOLOGY (2017)
Prevention of Amyloid-β and Tau Pathologies, Associated Neurodegeneration, and Cognitive Deficit by Early Treatment with a Neurotrophic Compound
Narjes Baazaoui et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Efficacy of Antidepressants for Depression in Alzheimer's Disease: Systematic Review and Meta-Analysis
Vasiliki Orgeta et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Cell-specific deletion of C1qa identifies microglia as the dominant source of C1q in mouse brain
Maria I. Fonseca et al.
JOURNAL OF NEUROINFLAMMATION (2017)
BACE1 Cleavage Site Selection Critical for Amyloidogenesis and Alzheimer's Pathogenesis
Shuting Zhang et al.
JOURNAL OF NEUROSCIENCE (2017)
Spread of tau down neural circuits precedes synapse and neuronal loss in the rTgTauEC mouse model of early Alzheimer's disease
Eleanor K. Pickett et al.
SYNAPSE (2017)
[18F]GE-180 PET Detects Reduced Microglia Activation After LM11A-31 Therapy in a Mouse Model of Alzheimer's Disease
Michelle L. James et al.
THERANOSTICS (2017)
Prevention of dendritic and synaptic deficits and cognitive impairment with a neurotrophic compound
Narjes Baazaoui et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
Evidence for mast cells contributing to neuromuscular pathology in an inherited model of ALS
Emiliano Trias et al.
JCI INSIGHT (2017)
Riluzole ameliorates learning and memory deficits in Aβ25-35-induced rat model of Alzheimer's disease and is independent of cholinoceptor activation
Zahra Mokhtari et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Association of Apolipoprotein E (ApoE) Polymorphism with Alzheimer's Disease in Chinese Population
Lingling Zheng et al.
CURRENT ALZHEIMER RESEARCH (2016)
Soluble A beta oligomers impair hippocampal LTP by disrupting glutamatergic/GABAergic balance
Ming Lei et al.
NEUROBIOLOGY OF DISEASE (2016)
Cognitive benefits of memantine in Alzheimer's 5XFAD model mice decline during advanced disease stages
Latha Devi et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2016)
Novel allele-dependent role for APOE in controlling the rate of synapse pruning by astrocytes
Won-Suk Chung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Complement and microglia mediate early synapse loss in Alzheimer mouse models
Soyon Hong et al.
SCIENCE (2016)
Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer's disease patients: application of a second-generation encapsulated cell biodelivery device
Helga Eyjolfsdottir et al.
ALZHEIMERS RESEARCH & THERAPY (2016)
Fyn inhibition rescues established memory and synapse loss in Alzheimer mice
Adam C. Kaufman et al.
ANNALS OF NEUROLOGY (2015)
FSD-C10: A more promising novel ROCK inhibitor than Fasudil for treatment of CNS autoimmunity
Yan-Le Xin et al.
BIOSCIENCE REPORTS (2015)
Microglia constitute a barrier that prevents neurotoxic protofibrillar Aβ42 hotspots around plaques
Carlo Condello et al.
NATURE COMMUNICATIONS (2015)
A phase Ib multiple ascending dose study of the safety, tolerability, and central nervous system availability of AZD0530 (saracatinib) in Alzheimer's disease
Haakon B. Nygaard et al.
ALZHEIMERS RESEARCH & THERAPY (2015)
A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer's disease
Michael S. Rafii et al.
ALZHEIMERS & DEMENTIA (2014)
Effect of Citalopram on Agitation in Alzheimer Disease The CitAD Randomized Clinical Trial
Anton P. Porsteinsson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease
Syed Faraz Kazim et al.
NEUROBIOLOGY OF DISEASE (2014)
Glutamatergic regulation prevents hippocampal-dependent age-related cognitive decline through dendritic spine clustering
Ana C. Pereira et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Efficacy and safety of cognitive enhancers for patients with mild cognitive impairment: a systematic review and meta-analysis
Andrea C. Tricco et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2013)
Amyloid- protein (A) Glu11 is the major -secretase site of -site amyloid- precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to A Asp1 contributes to Alzheimer pathogenesis
Yu Deng et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2013)
Synaptic alterations in the rTg4510 mouse model of tauopathy
Katherine J. Kopeikina et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2013)
A Dramatic Increase of C1q Protein in the CNS during Normal Aging
Alexander H. Stephan et al.
JOURNAL OF NEUROSCIENCE (2013)
NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice
Michael T. Heneka et al.
NATURE (2013)
Cellular Source-Specific Effects of Apolipoprotein (Apo) E4 on Dendrite Arborization and Dendritic Spine Development
Sachi Jain et al.
PLOS ONE (2013)
Aβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss
Maria Talantova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Gene Transfer of Human Apoe Isoforms Results in Differential Modulation of Amyloid Deposition and Neurotoxicity in Mouse Brain
Eloise Hudry et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Impaired plasticity of cortical dendritic spines in P301S tau transgenic mice
Nadine A. Hoffmann et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2013)
The Complement System: An Unexpected Role in Synaptic Pruning During Development and Disease
Alexander H. Stephan et al.
ANNUAL REVIEW OF NEUROSCIENCE, VOL 35 (2012)
The Complex PrPc-Fyn Couples Human Oligomeric Aβ with Pathological Tau Changes in Alzheimer's Disease
Megan Larson et al.
JOURNAL OF NEUROSCIENCE (2012)
Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons
Ji Won Um et al.
NATURE NEUROSCIENCE (2012)
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Dorothy P. Schafer et al.
NEURON (2012)
Dendritic Degeneration, Neurovascular Defects, and Inflammation Precede Neuronal Loss in a Mouse Model for Tau-Mediated Neurodegeneration
Tomasz Jaworski et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Soluble Aβ Oligomers Inhibit Long-Term Potentiation through a Mechanism Involving Excessive Activation of Extrasynaptic NR2B-Containing NMDA Receptors
Shaomin Li et al.
JOURNAL OF NEUROSCIENCE (2011)
Amyloid-β/Fyn-Induced Synaptic, Network, and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer's Disease
Erik D. Roberson et al.
JOURNAL OF NEUROSCIENCE (2011)
Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial
Sube Banerjee et al.
LANCET (2011)
Microglia in development: linking brain wiring to brain environment
Rosa C. Paolicelli et al.
NEURON GLIA BIOLOGY (2011)
Changes in dendritic complexity and spine morphology in transgenic mice expressing human wild-type tau
Dara L. Dickstein et al.
BRAIN STRUCTURE & FUNCTION (2010)
Structural and functional changes in tau mutant mice neurons are not linked to the presence of NFTs
A. B. Rocher et al.
EXPERIMENTAL NEUROLOGY (2010)
Neurotrophic peptides incorporating adamantane improve learning and memory, promote neurogenesis and synaptic plasticity in mice
Bin Li et al.
FEBS LETTERS (2010)
Efficacy of SSRIs on cognition of Alzheimer's disease patients treated with cholinesterase inhibitors
Luca Rozzini et al.
INTERNATIONAL PSYCHOGERIATRICS (2010)
Distribution of VGF peptides in the human cortex and their selective changes in Parkinson's and Alzheimer's diseases
Cristina Cocco et al.
JOURNAL OF ANATOMY (2010)
Aβ Oligomers Cause Localized Ca2+ Elevation, Missorting of Endogenous Tau into Dendrites, Tau Phosphorylation, and Destruction of Microtubules and Spines
Hans Zempel et al.
JOURNAL OF NEUROSCIENCE (2010)
Co-occurrence of Alzheimer's disease β-amyloid and tau pathologies at synapses
Reisuke H. Takahashi et al.
NEUROBIOLOGY OF AGING (2010)
Transsynaptic Progression of Amyloid-β-Induced Neuronal Dysfunction within the Entorhinal-Hippocampal Network
Julie A. Harris et al.
NEURON (2010)
Expression of complement system components during aging and amyloid deposition in APP transgenic mice
Julia Reichwald et al.
JOURNAL OF NEUROINFLAMMATION (2009)
Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease
O. L. Lopez et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)
Amyloid β-Induced Nerve Growth Factor Dysmetabolism in Alzheimer Disease
Martin A. Bruno et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
Age-Dependent Impairment of Cognitive and Synaptic Function in the htau Mouse Model of Tau Pathology
Manuela Polydoro et al.
JOURNAL OF NEUROSCIENCE (2009)
Oligomeric amyloid β associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques
Robert M. Koffie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer disease
Susan D Rountree et al.
Alzheimers Research & Therapy (2009)
Failure of neuronal maturation in Alzheimer disease dentate gyrus
Bin Li et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer's disease
Melanie Meyer-Luehmann et al.
NATURE (2008)
Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
Ganesh M. Shankar et al.
NATURE MEDICINE (2008)
The classical complement cascade mediates CNS synapse elimination
Beth Stevens et al.
CELL (2007)
Does fluoxetine have any effect on the cognition of patients with mild cognitive impairment? A double-blind, placebo-controlled, clinical trial
Arash Mowla et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2007)
Aβ oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease
Pascale N. Lacor et al.
JOURNAL OF NEUROSCIENCE (2007)
Domain-specific improvement of cognition on memantine in patients with Alzheimer's disease treated with rivastigmine
Matthias W. Riepe et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2007)
N-(5-Chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-(tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine, a novel, highly selective, orally available, dual-specific c-Src/Abl kinase inhibitor
Laurent F. Hennequin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment
Stephen W. Scheff et al.
NEUROBIOLOGY OF AGING (2006)
Control of APP processing and Aβ generation level by BACE1 enzymatic activity and transcription
Yu Li et al.
FASEB JOURNAL (2006)
Assessing therapeutic efficacy in a progressive disease - A study of donepezil in Alzheimer's disease
Peter Johannsen et al.
CNS DRUGS (2006)
Circadian cholinergic rhythms: Implications for cholinesterase inhibitor therapy
B Davis et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2006)
Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms
C Andorfer et al.
JOURNAL OF NEUROSCIENCE (2005)
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
A Nimmerjahn et al.
SCIENCE (2005)
A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease
MH Tuszynski et al.
NATURE MEDICINE (2005)
Amyloid β protein immunotherapy neutralizes Aβ oligomers that disrupt synaptic plasticity in vivo
I Klyubin et al.
NATURE MEDICINE (2005)
Cognitive performance in Alzheimer's disease patients receiving rivastigmine for up to 5 years
GW Small et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2005)
Short-term treatment with the antidepressant fluoxetine triggers pyramidal dendritic spine synapse formation in rat hippocampus
T Hajszan et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Increased hippocampal neurogenesis in Alzheimer's disease
KL Jin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Absence of C1q leads to less neuropathology in transgenic mouse models of Alzheimer's disease
MI Fonseca et al.
JOURNAL OF NEUROSCIENCE (2004)
Efficacy of donepezil in early-stage Alzheimer disease - A randomized placebo-controlled trial
B Seltzer et al.
ARCHIVES OF NEUROLOGY (2004)
Amyloid β prevents activation of calcium/calmodulin-dependent protein kinase II and AMPA receptor phosphorylation during hippocampal long-term potentiation
DY Zhao et al.
JOURNAL OF NEUROPHYSIOLOGY (2004)
A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezil
SI Finkel et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2004)
Memantine in moderate-to-severe Alzheimer's disease
B Reisberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo
DM Walsh et al.
NATURE (2002)
The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease
M Fahnestock et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2001)
A double-blind, placebo-controlled study of fluoxetine in depressed patients with Alzheimer's disease
GM Petracca et al.
INTERNATIONAL PSYCHOGERIATRICS (2001)
Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial
GK Wilcock et al.
BRITISH MEDICAL JOURNAL (2000)
Staging of cytoskeletal and β-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease
EB Mukaetova-Ladinska et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Presenilins are required for γ-secretase cleavage of β-APP and transmembrane cleavage of Notch-1
ZH Zhang et al.
NATURE CELL BIOLOGY (2000)
A 5-month, randomized, placebo-controlled trial of galantamine in AD
PN Tariot et al.
NEUROLOGY (2000)
High-level neuronal expression of Aβ1-42 in wild-type human amyloid protein precursor transgenic mice:: Synaptotoxicity without plaque formation
L Mucke et al.
JOURNAL OF NEUROSCIENCE (2000)
分享论文
